Oct. 26 (UPI) -- The vaccines advisory committee to the Food and Drug Administration on Tuesday voted to recommend that Pfizer's COVID-19 vaccine be approved for children between 5 and 11 years old.
The Vaccines and Related Biological Products Advisory Committee convened Tuesday morning to hear presentations for several hours before it held the vote. The FDA will consider the recommendation before deciding whether to grant emergency authorization for smaller doses vaccine for children in the younger age range.